https://www.forbes.com/sites/amyfeldman/2020/05/28/biotech-rd-software-startup-benchling-started-by-mit-undergrads-scores-850-million-valuation-amid-coronavirus-pandemic/
0
0
5/28/20 at 10:30am
Organization
Forbes
Forbes Under 30 alum Sajith Wickramasekara scores an $850 million valuation for his biotech R&D startup Benchling. Amid the coronavirus pandemic, the company is helping big biotech companies work on potential therapeutics and vaccines for Covid-19.
Create an account
or login to join the discussion